Viagra vs. Cialis: Little Blue Pill Is Losing Big

Dec. 19 (Bloomberg) -- Bloomberg's Eric Chemi take a look at the two most popular erectile dysfunction medications on the market, Viagra and Cialis. Pfizer, the maker of Viagra, eliminated 20% of its sales workforce on December 18.

Breaking Down Japan's Inflation Data
09:34 - Mikio Kumada, global strategist and executive director at LGT Capital Partners, discusses Japanese inflation and unemployment data and what they mean for the economy. He speaks to Bloomberg's Anna Edwards on "Countdown." (Source: Bloomberg)
  • France, Russia to Coordinate Strikes on Syria
  • London's Next Top Property Hot Spots
  • Christie's Says 2015 Auctions on Track to Match Record